ORGANON & CO.
Last · —$13.74-0.03 (-0.22%)live · yahoo · 1h ago
Vol 1.81M ≈ 24.83M
MA10MA20MA50
Market cap$3.61B—
P/E · TTM17.6fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameORGANON & CO.
HQUnited States (US)
ListingUS OGN
ISINUS68622V1061
SectorHealthcare
IndustryPharmaceuticals
SIC2834
CurrencyUSD
Entity registrysec:0001821825
CIK0001821825
Websitewww.organon.com
Employees10,000
AddressOrganon & Co. 30 Hudson Street 07302, Jersey City +551 430 6900
| Revenue | $3.0B |
|---|---|
| Operating income | $396.0M |
| Net income | $254.0M |
| Free cash flow | $253.0M |
| Operating margin | 13.1% |
| Net margin | 8.4% |
| Return on equity | 25.2% |
| Period | 2026 |
Loading chart…
Upcoming earnings
MON.9NOV
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.88
Est. revenue
1.6B
Earnings transcripts
Documents
FormReporting forFiledFlags
Showing 5 of 12 filings